Press Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jul 23, 2013Conference Call and Webcast scheduled for August 13, 2013, 8:00 a.m. ET
Aratana Therapeutics, Inc. (NASDAQ: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative prescription medications for...
-
Jul 11, 2013
Aratana Therapeutics, Inc. (NASDAQ: PETX), a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative prescription medications for...
-
Jun 27, 2013
Aratana Therapeutics, Inc., a development-stage biopharmaceutical company focused on the licensing, development and commercialization...
-
Mar 26, 2013Marie-Paul Lachaud, D.V.M., to Expand European Operations
Aratana Therapeutics, Inc., a biopharmaceutical company focused on licensing, developing and commercializing innovative prescription...
-
Mar 20, 2013
Aratana Therapeutics, Inc., a biopharmaceutical company focused on licensing, developing and commercializing innovative prescription...
-
Mar 7, 2013
Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced...
-
Feb 12, 2013
Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today...
-
Jan 31, 2013
Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced...
-
Jan 24, 2013
Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced the appointment of Erick Lucera as Vice President of...
-
Jan 15, 2013
Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced it has appointed an experienced animal health executive...